Degroof Petercam Initiates the Coverage of Aelis Farma With a Buy Recommendation streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS) (Paris:AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, today announces
2022 objectives successfully met, notably in the development of the two drug candidates: AEF0117: phase 2b study in the United States progressing as expected AEF0217: the compound's
Aelis Farma Reports Its 2022 Annual Financial Results and Confirms Its 2023 Outlook pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Aelis Farma Has Participated in Two Symposiums Marking World Down Syndrome Day streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.